Table 2 Clinical outcome of critical trauma patients (n = 23) according to argininemia and plasma arginine bioavailability at the ICU admission
Argininemia <26 μmol/L vs ≥26 μmol/L | P a | Plasma arginine bioavailability <42 % vs ≥42 % | P a | |
|---|---|---|---|---|
In-hospital mortality (%) | 75 vs 15.8 | 0.04 | 66.7 vs 11.8 | 0.021 |
Health care-associated infections rate (%) | 75 vs 89.5 | n.s. | 83.3 vs 88.2 | n.s. |
Invasive ventilation period (days) | 6.3 ± 3.5 vs 14.1 ± 7.8 | 0.01 | 8.5 ± 6.7 vs 14.2 ± 7.7 | n.s. |
ICU length of stay (days) | 7 ± 3.6 vs 15.4 ± 9.3 | 0.01 | 9.5 ± 6.7 vs 15.5 ± 9.5 | n.s. |
Hospital length of stay (days) | 15.3 ± 9.3 vs 32.4 ± 22.8 | n.s. | 21.8 ± 17.8 vs 32.1 ± 23.1 | n.s. |
Mean actuarial survival (days) | 63.5 ± 43.9 vs 256.1 ± 33.3 | 0.031 | 87.2 ± 37.5 vs 261.4 ± 34.7 | n.s. |
Performance status (Karnofsky’s index) | 50 ± 0 vs 71.1 ± 16.9 | n.s. | 65 ± 21.2 vs 70 ± 17.7 | n.s. |